Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 7
2000 6
2001 2
2002 5
2003 4
2004 1
2005 7
2006 13
2007 14
2008 15
2009 14
2010 31
2011 61
2012 47
2013 39
2014 44
2015 44
2016 33
2017 34
2018 25
2019 15
2020 18
2021 23
2022 15
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber L, Ueki Y, Otsuka T, Losdat S, Häner JD, Lonborg J, Fahrni G, Iglesias JF, van Geuns RJ, Ondracek AS, Radu Juul Jensen MD, Zanchin C, Stortecky S, Spirk D, Siontis GCM, Saleh L, Matter CM, Daemen J, Mach F, Heg D, Windecker S, Engstrøm T, Lang IM, Koskinas KC; PACMAN-AMI collaborators. Räber L, et al. Among authors: van geuns rj. JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218. JAMA. 2022. PMID: 35368058 Free PMC article. Clinical Trial.
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.
Biccirè FG, Häner J, Losdat S, Ueki Y, Shibutani H, Otsuka T, Kakizaki R, Hofbauer TM, van Geuns RJ, Stortecky S, Siontis GCM, Bär S, Lønborg J, Heg D, Kaiser C, Spirk D, Daemen J, Iglesias JF, Windecker S, Engstrøm T, Lang I, Koskinas KC, Räber L. Biccirè FG, et al. Among authors: van geuns rj. J Am Coll Cardiol. 2023 Oct 31;82(18):1737-1747. doi: 10.1016/j.jacc.2023.08.019. Epub 2023 Aug 26. J Am Coll Cardiol. 2023. PMID: 37640248
Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
Camaro C, Aarts GWA, Adang EMM, van Hout R, Brok G, Hoare A, Rodwell L, de Pooter F, de Wit W, Cramer GE, van Kimmenade RRJ, Damman P, Ouwendijk E, Rutten M, Zegers E, van Geuns RM, Gomes MER, van Royen N. Camaro C, et al. Eur Heart J. 2023 May 14;44(19):1705-1714. doi: 10.1093/eurheartj/ehad056. Eur Heart J. 2023. PMID: 36755110 Free PMC article. Clinical Trial.
Effect of Face-to-Face vs Virtual Reality Training on Cardiopulmonary Resuscitation Quality: A Randomized Clinical Trial.
Nas J, Thannhauser J, Vart P, van Geuns RJ, Muijsers HEC, Mol JQ, Aarts GWA, Konijnenberg LSF, Gommans DHF, Ahoud-Schoenmakers SGAM, Vos JL, van Royen N, Bonnes JL, Brouwer MA. Nas J, et al. Among authors: van geuns rj. JAMA Cardiol. 2020 Mar 1;5(3):328-335. doi: 10.1001/jamacardio.2019.4992. JAMA Cardiol. 2020. PMID: 31734702 Free PMC article. Clinical Trial.
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators. Vranckx P, et al. Among authors: van geuns rj. Lancet. 2018 Sep 15;392(10151):940-949. doi: 10.1016/S0140-6736(18)31858-0. Epub 2018 Aug 27. Lancet. 2018. PMID: 30166073 Clinical Trial.
Myocardial 'no-reflow' prevention.
Magro M, Springeling T, van Geuns RJ, Zijlstra F. Magro M, et al. Among authors: van geuns rj. Curr Vasc Pharmacol. 2013 Mar 1;11(2):263-77. Curr Vasc Pharmacol. 2013. PMID: 23506503 Review.
The year in review: coronary interventions.
Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns RM, Capodanno D, Byrne RA, Wijns W, Onuma Y, Serruys PW. Gao C, et al. EuroIntervention. 2020 Apr 17;15(17):1534-1547. doi: 10.4244/EIJ-D-19-01124. EuroIntervention. 2020. PMID: 32091399 Free article. Review. No abstract available.
The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX.
Gao C, Kogame N, Modolo R, Takahashi K, Wang R, Kawashima H, Ono M, Hara H, Tomaniak M, Zaman A, de Winter RJ, van Geuns RJ, Kaul U, Serruys PW, Onuma Y. Gao C, et al. Among authors: van geuns rj. Future Cardiol. 2021 Mar;17(2):227-237. doi: 10.2217/fca-2019-0083. Epub 2020 Sep 10. Future Cardiol. 2021. PMID: 32907391 Review.
P2Y12 blocker monotherapy after percutaneous coronary intervention.
Verheugt FWA, Damman P, Damen SAJ, Wykrzykowska JJ, Woelders ECI, van Geuns R-M. Verheugt FWA, et al. Neth Heart J. 2021 Nov;29(11):566-576. doi: 10.1007/s12471-021-01582-7. Epub 2021 Jun 8. Neth Heart J. 2021. PMID: 34101134 Free PMC article. Review.
474 results